Latest DEF 14A proxy statements

Opendoor Technologies Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to vote on director elections, auditor ratification, and executive compensation.

Maze Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 8, 2026, to elect directors and ratify auditor appointment.

PACS Group, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, a virtual event, and has proposed the re-election of two Class II directors.

CTO Realty Growth, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with key proposals including director elections and equity plan approval.

Vuzix Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.

RxSight, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 16, 2026, with April 21, 2026, as the record date.

TechTarget, Inc. announced its 2026 Annual Meeting of Stockholders will be held on June 11, 2026, to elect directors, ratify auditors, and vote on executive compensation.

TeraWulf Inc. invites stockholders to its 2026 Annual Meeting on June 9, 2026, to vote on director elections, executive compensation, and auditor ratification, with materials available online.

BEST SPAC I Acquisition Corp. is holding an Extraordinary General Meeting on May 19, 2026, to seek shareholder approval to extend its deadline for consummating a business combination by twelve months, from June 16, 2026, to June 16, 2027.

GrowGeneration Corp. announced its 2026 Annual Meeting of Shareholders will be held virtually on June 18, 2026, detailing proposals including director elections, executive compensation advisory vote, equity plan amendment, and auditor ratification.

Nuvalent, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Incyte Corporation announces its 2026 Annual Meeting of Shareholders, detailing director elections, executive compensation, and auditor ratification, alongside a strong 2025 performance review.

BKV Corporation's proxy statement details the upcoming 2026 Annual Meeting of Stockholders, focusing on director elections and auditor ratification, while highlighting 2025 achievements and strategic direction.

vTv Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, to elect directors and ratify auditor appointment.

BigBear.ai Holdings, Inc. has issued its 2026 proxy statement, detailing proposals for the upcoming Annual Meeting of Stockholders on June 9, 2026, including director elections, executive compensation votes, and a stock increase amendment.

AppFolio, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Whitehawk Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.

GRAIL, Inc. is holding its 2026 Annual Meeting of Stockholders on June 18, 2026, and announced the planned retirement of CEO Robert Ragusa, with President Dr. Joshua Ofman set to take over as CEO.

Slide Insurance Holdings, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors and ratify the appointment of its independent auditor.

eHealth, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, ratify auditor appointment, and approve an equity incentive plan amendment.

Janux Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Puma Biotechnology, Inc. has announced its 2026 annual meeting of stockholders, scheduled for June 11, 2026, to elect directors, ratify auditors, and vote on executive compensation and an extension of CEO Alan H. Auerbach's warrant.

Rocky Brands announces its annual shareholder meeting on June 3, 2026, to elect directors, vote on executive compensation, and ratify auditors.

Context Therapeutics Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, and is seeking approval to increase its authorized common stock.

Akebia Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, and proposes a significant increase in authorized common stock.

Jade Biosciences, Inc. has issued its proxy statement, inviting stockholders to its 2026 Annual Meeting of Stockholders on June 9, 2026, to vote on director elections, auditor ratification, and a charter amendment.

Inogen, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 5th, proposing key governance changes including the declassification of its Board of Directors.

Nautilus Biotechnology, Inc. has issued its definitive proxy statement, announcing its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Tarsus Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 25, 2026, with key proposals including director elections and executive compensation.

Fennec Pharmaceuticals Inc. has issued its proxy statement for the Annual and Special Meeting of Shareholders scheduled for June 10, 2026, detailing proposals for director elections, auditor appointments, executive compensation votes, and equity plan amendments.